Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Impot Res ; 24(2): 69-76, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21975567

RESUMO

Erectile dysfunction (ED) mechanisms in diabetic patients are multifactorial and often lead to resistance to current therapy. Animal toxins have been used as pharmacological tools to study penile erection. Human accidents involving the venom of Phoneutria nigriventer spider are characterized by priapism. We hypothesize that PnTx2-6 potentiates cavernosal relaxation in diabetic mice by increasing cyclic guanosine monophosphate (cGMP). This effect is neuronal nitric oxide synthase (nNOS) dependent. Cavernosal strips were contracted with phenylephrine (10(-5) M) and relaxed by electrical field stimulation (20 V, 1-32 Hz) in the presence or absence of PnTx2-6 (10(-8) M). Cavernosal strips from nNOS- and endothelial nitric oxide synthase (eNOS)-knockout (KO) mice, besides nNOS inhibitor (10(-5) M), were used to evaluate the role of this enzyme in the potentiation effect evoked by PnTx2-6. Tissue cGMP levels were determined after stimulation with PnTx2-6 in presence or absence of N-nitro-L-arginine methyl ester (L-NAME) (10(-4) M) and ω-conotoxin GVIA (10(-6) M), an N-type calcium channel inhibitor. Results showed that PnTx2-6 enhanced cavernosal relaxation in diabetic mice (65%) and eNOS KO mice, but not in nNOS KO mice. The toxin effect in the cavernosal relaxation was abolished by nNOS inhibitor. cGMP levels are increased by PnTx2-6, however, L-NAME abolished this enhancement as well as ω-conotoxin GVIA. We conclude that PnTx2-6 facilitates penile relaxation in diabetic mice through a mechanism dependent on nNOS, probably via increasing nitric oxide/cGMP production.


Assuntos
Diabetes Mellitus Experimental/complicações , Disfunção Erétil/tratamento farmacológico , Óxido Nítrico Sintase Tipo I/metabolismo , Pênis/efeitos dos fármacos , Peptídeos/uso terapêutico , Venenos de Aranha/uso terapêutico , Animais , GMP Cíclico/metabolismo , Avaliação Pré-Clínica de Medicamentos , Disfunção Erétil/complicações , Disfunção Erétil/enzimologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , NG-Nitroarginina Metil Éster , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo III/metabolismo , Peptídeos/farmacologia , Transdução de Sinais/efeitos dos fármacos , Venenos de Aranha/farmacologia , ômega-Conotoxina GVIA
2.
J Neurochem ; 72(4): 1472-81, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10098851

RESUMO

GH3 cells present spontaneous Ca2+ action potentials and oscillations of intracellular Ca2+, which can be modified by altering the activity of K+ or Ca2+ channels. We took advantage of this spontaneous activity to screen for effects of a purified toxin (Tx3-1) from the venom of Phoneutria nigriventer on ion channels. We report that Tx3-1 increases the frequency of Ca2+ oscillations, as do two blockers of potassium channels, 4-aminopyridine and charybdotoxin. Whole-cell patch clamp experiments show that Tx3-1 reversibly inhibits the A-type K+ current (I(A)) but does not block other K+ currents (delayed-rectifying, inward-rectifying, and large-conductance Ca2+-sensitive) or Ca2+ channels (T and L type) in these cells. In addition, we describe the sequence of a full cDNA clone of Tx3-1, which shows that Tx3-1 has no homology to other known blockers of K+ channels and gives insights into the processing of this neurotoxin. We conclude that Tx3-1 is a selective inhibitor of I(A), which can be used to probe the role of this channel in the control of cellular function. Based on the effect of Tx3-1, we suggest that I(A) is an important determinant of the frequency of Ca2+ oscillations in unstimulated GH3 cells.


Assuntos
Cálcio/metabolismo , Neuropeptídeos/farmacologia , Periodicidade , Canais de Potássio/fisiologia , Venenos de Aranha/farmacologia , 4-Aminopiridina/farmacologia , Sequência de Aminoácidos , Sequência de Bases , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/fisiologia , Linhagem Celular , Charibdotoxina/farmacologia , Quelantes/farmacologia , DNA Complementar/isolamento & purificação , Ácido Egtázico/farmacologia , Ativação do Canal Iônico/efeitos dos fármacos , Ativação do Canal Iônico/fisiologia , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Dados de Sequência Molecular , Neuropeptídeos/genética , Nifedipino/farmacologia , Técnicas de Patch-Clamp , Hipófise/química , Hipófise/citologia , Bloqueadores dos Canais de Potássio , Venenos de Aranha/genética
3.
Toxicon ; 36(12): 1971-80, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9839681

RESUMO

The cDNAs (Tx3-2 and Pn3A) encoding precursor of toxin Tx3-2 and an isoform called Pn3A have been isolated from a library constructed from stimulated venom glands of the spider Phoneutria nigriventer. The cDNA of Tx3-2 reveals the presence of a signal peptide of 21 amino acids and of an intervening propeptide (with 16 amino acids) preceding the toxin sequence, which was followed by additional amino acid residues at the C-terminus (C-terminal peptide), implying post-translational modifications of the synthesised peptide. The deduced amino acid sequence for the mature toxin confirms the previous sequence published. In addition, by using the whole-cell patch clamp technique, we have determined that purified Tx3-2 decreases L-type currents present in GH3 cells. Finally, the presence of the cDNA Pn3A, with high sequence identity with Tx3-2, reveals the existence of a putative new toxin showing, at the cDNA level, 85.4% identity in its whole segment.


Assuntos
Canais de Cálcio/efeitos dos fármacos , Peptídeos/genética , Venenos de Aranha/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Northern Blotting , Clonagem de Organismos , DNA Complementar/química , Biblioteca Gênica , Dados de Sequência Molecular , Técnicas de Patch-Clamp , Sinais Direcionadores de Proteínas , Venenos de Aranha/classificação , Venenos de Aranha/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA